Sunday 17 October is the day you can come and discover the brand new Jules Bordet Institute
The Jules Bordet Institute, the reference centre in the fight against cancer in Belgium.
The Jules Bordet Institute, the reference centre in the fight against cancer in Belgium.
The RESTART programme: personalised follow-up for persons with breast cancer in remission.
For the third year, a team of patients from the Jules Bordet Institute is preparing to take part in the Brussels 20 km
L’observance aux anticancéreux oraux : les enjeux de la multiculturalité - Sandra Michiels
Pr. F. Meunier and Pr. JP Sculier : Atelier Marcel Hastir
In vieuw of the news : « COVID-19 » by Pr. Aoun
Annulation of the seminar
Les défis et opportunités des dons de tissus post-mortem dans le contexte de la recherche sur le cancer.
Centres du cancer : ce que l’Europe nous prépare. (Dr JB Burrion, Institut Bordet)
Economie de santé et droits des patients (Alain de Wever, ULB)
Innovation in Radiotherapy : FLASH-therapy (Jean BOURHIS, MD PhD) Lausanne University Hospital, Switzerland
Determination of new clinico-pathological pronostic factors in patients with colorectal and ovarian peritoneal mestastases. Dr Antoine El Asmar, Prof. Gabriel Liberale, Chirurgie des Tumeurs Abdominales, IJB.
Néoplasie de la prostate - thrombopénie (J. Catherine, S. Wittnebel/N. Meuleman, R. De Wind
ESTRO 2022 - Dr Bodson Elisa
MLC verification on the Unity with a multi-array phantom - Mr Kevin Tihon
New CTsim: clinical implementation and protocol optimization (BURGHELEA M.)
Predicting overall survival using 18F-FDG PET/CT-based biomarkers for clinical decision support in metastatic colorectal cancer - Dr Jennifer Dhont
Predictive biomarkers in PRRT (Dr Mileva et Dr Karfis)
Toxicité grave du traitement par CAR-T Cells (Charles Dehout - Vito Fontana)
Mélanome métastatique – manifestations auto-immunes (A.Drowar, T. Gustot (Erasme)